In a study published this year in
Current Drug Targets, a combination of tocotrienols and quercetin induced senescence and promoted apoptosis in many different types of cancer cells, while delaying senescence in healthy cells and rejuvenating formerly healthy senescent cells.
McGeer EG, McGeer PL, Abeta immunotherapy and other methods of reducing amyloid,
Current Drug Targets - CNS & Neurological Disorders 4:569 - 573, 2005 715.
As a result, this approach is severely under - exploited, despite the fact that the extensive human interactome presents opportunities that dwarf
current drug targets.
Moreover, the binding with the MMP active site is discussed in the research paper, «Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors», published in
Current Drug Targets.
In fact, a predominant number of
current drugs target the GPCR signaling.
Not exact matches
The institute, which includes over 40 laboratories and more than 300 researchers, said the research would focus on modifying a patient's own immune system T - cells to
target a tumor, studying ways to boost patient response to
current immunotherapy
drugs.
She said
current drug laws disproportionately
target people of color.
Wang points out that the
current findings are preliminary and that comparing SLC13A5 activity in healthy and cancerous human liver tissue will be necessary before studies of this pathway as a cancer
drug target should be contemplated.
In a paper published in the
current online issue of the journal Small, titled «Immune Cell - Mediated Biodegradable Theranostic Nanoparticles for Melanoma
Targeting,» the researchers report the use of a novel biodegradable and photoluminescent poly (lactic acid) nanoparticle, loaded with melanoma - specific
drugs with immune cells as the nanoparticle carriers.
It also suggests the possibility of designing better sleeping pills by finding compounds that mimic adenosine's effects, says McCarley, who points out that
current drugs do not
target the adenosine receptors.
Researches are also testing
drugs that
target the VNN - 1 pathway to determine which, if any, might improve treatment for asthmatic children who do not respond to
current treatments.
A
drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to
current targeted therapies, according to a Duke Cancer Institute study.
«It can suppress many of the disease's signaling pathways, which
current drugs on the market now try to
target and treat.»
Learning why
current anesthetics are so potent and sometimes dangerous will lead to a new generation of safer
targeted drugs without unwanted side effects
«
Current antiretroviral
drugs target HIV's proteins,» says James Stivers, Ph.D., a professor of pharmacology and molecular sciences at the Johns Hopkins University School of Medicine, «but those proteins are moving
targets because they are often altered by mutations.
Drugs that specifically
target the persistent sodium ion flow, or
current, have been approved by the Food and
Drug Administration for treating epilepsy.
«Instead of
targeting mGluR5, which is a very widespread molecule with many different functions, now we can
target the persistent sodium
current directly, using already approved
drugs that are more specific and less likely to cause side effects,» Klyachko said.
«At Exeter we are already developing specific psychological therapies, running clinical trials of novel
drug approaches and using - cutting edge genetic techniques to identify new
targets for safe and effective therapies and to allow us to use
current treatments in a more focussed way.»
Current antimalarial
drugs are becoming less effective as the parasite develops resistance to the
drugs, making the search for new
targets that can kill all species of malaria critical.
«All
current weight loss
drugs control appetite, and there is nothing on the market that
targets energy expenditure.
«
Current therapies take advantage of this by using
targeted drugs such as Trastuzumab or Lapatinib to specifically inhibit ERBB2, but eventually they become ineffective as the cancer develops resistance to those
drugs.»
This is the first time that an Osmium - based compound — which is fifty times more active than the
current cancer
drug cisplatin — has been seen to
target the disease.
This specificity could be valuable because
current anti-influenza
drugs target other parts of the virus, Jacob says.
Current drugs for metabolic diseases rely on hormones that are systemic throughout the entire body or
drugs that
target entire proteins.
-- In a blog post, Jay Bradner, the former head of Dana - Farber Cancer Institute and the
current president of Novartis Institutes for Biomedical Research, wrote that too many investment dollars have gone into redundant cancer programs, such as more checkpoint inhibitors, rather than going after tougher
drug targets that might have a greater future impact.
Illustrating the tricky path
current Alzheimer's research faces, the study was published literally hours after giant pharmaceutical company Merck announced the cancellation of a Phase 3 clinical trial surrounding a
drug that
targets the exact same enzyme.
Caribou is advancing its CRISPR - Cas9 platform in
drug target screening and validation to help overcome the limitations of
current RNAi - based approaches.
Erinna says that based on
current results, the researchers now believe that a
drug targeting BFL - 1 could be highly effective for treatment of melanoma, particularly if used in combination with the currently available MCL -1-
targeting molecule.
Current projects in the laboratory include: 1) functional screens of ubiquitin ligases to identify novel cancer
drug targets; 2) defining the molecular regulation of breast cancer metastasis to the brain; and 3) understanding signaling pathways that influence the response of cancer cells to chemotherapy.
80 percent of all
current drugs affect membrane proteins, and more than 50 percent of all
drugs target them directly.
Current melanoma
drugs targeting single proteins can initially be effective, but resistance develops relatively quickly and the disease recurs.
Acetylcholine receptor, which is the
target of
drugs (nicotine, ethanol) and
current therapeutics (anaesthetics, anxiolytics, anti-smoking and anti-Alzheimer's).
However, for the majority
targeted therapies in development — and their combinations with
current standard therapies — there are still no approved diagnostic tools to determine which patients are most likely to benefit from or be resistant to these novel agents or
drug combinations.
In contrast to the
current drugs that
target one protein or one mechanism, microRNA - based AMD therapy provides a unique «one - molecule, multiple -
targets» model for disease treatment, which fits particularly well with the complex nature of AMD.
ORIC Pharmaceuticals, Inc. is a small molecule oncology company focused on combating the growing resistance problem to
current molecularly
targeted drugs.
ORIC is a small molecule oncology company focused on combating the growing resistance problem to
current molecularly
targeted drugs.
His
current research focuses on chemical evolution of sequence - defined carriers for
drugs, proteins and therapeutic nucleic acids, with a medical focus on tumor -
targeted therapies.
«The task was to find the rogue proteins in cancer and go after them and spare the normal cells,» says Buolomwini, who later founded the journal
Current Cancer
Drug Targets to chronicle the field.
The findings could lead to improved effectiveness of
current treatments for IBD, as well as the discovery of new
drug targets, the study authors said.
A
drug which
targets insulin signalling appears to restore insulin sensitivity in mice Type 2 diabetes is a massive burden on healthcare systems around the world, and while
current treatments are able to manage many aspects of the condition, they are not curative.
You'll see similar ones about «curing cancer» when they've identified a new protein that MIGHT be a
drug target, against which
drugs MIGHT be developed, which MIGHT or MIGHT NOT be better than
current drugs and which will only come to market in 15 years.